CCL-DTI: contributing the contrastive loss in drug–target interaction prediction
暂无分享,去创建一个
[1] Parvin Razzaghi,et al. DeepCompoundNet: enhancing compound-protein interaction prediction with multimodal convolutional neural networks. , 2023, Journal of biomolecular structure & dynamics.
[2] S. Gharaghani,et al. TripletMultiDTI: Multimodal representation learning in drug-target interaction prediction with triplet loss function , 2023, Expert Syst. Appl..
[3] Minzhu Xie,et al. Graph regularized non-negative matrix factorization with \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$L_{2,1}$$\end , 2023, BMC Bioinformatics.
[4] Li Zhang,et al. GPCNDTA: Prediction of drug-target binding affinity through cross-attention networks augmented with graph features and pharmacophores , 2023, Comput. Biol. Medicine.
[5] Q. Zhang,et al. MCL-DTI: using drug multimodal information and bi-directional cross-attention learning method for predicting drug–target interaction , 2023, BMC Bioinformatics.
[6] Runze Ma,et al. Cross-view contrastive representation learning approach to predicting DTIs via integrating multi-source information. , 2023, Methods.
[7] Xiaoqiong Xia,et al. MDTips: a multimodal-data-based drug–target interaction prediction system fusing knowledge, gene expression profile, and structural data , 2023, Bioinformatics.
[8] Hongmin Cai,et al. A survey of drug-target interaction and affinity prediction methods via graph neural networks , 2023, Comput. Biol. Medicine.
[9] Zhonglu Ren,et al. SSELM-neg: spherical search-based extreme learning machine for drug–target interaction prediction , 2023, BMC Bioinformatics.
[10] Zhenjiang Zhao,et al. MOVE: Integrating Multi-source Information for Predicting DTI via Cross-view Contrastive Learning , 2022, 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[11] Xing Chen,et al. Predicting drug-target binding affinity through molecule representation block based on multi-head attention and skip connection , 2022, Briefings Bioinform..
[12] Craig J. Neal,et al. AttentionSiteDTI: an interpretable graph-based model for drug-target interaction prediction using NLP sentence-level relation classification , 2022, Briefings Bioinform..
[13] J. Guan,et al. Effective drug–target interaction prediction with mutual interaction neural network , 2022, Bioinform..
[14] Ozlem O. Garibay,et al. UnbiasedDTI: Mitigating Real-World Bias of Drug-Target Interaction Prediction by Using Deep Ensemble-Balanced Learning , 2022, Molecules.
[15] Guohua Wang,et al. Supervised graph co-contrastive learning for drug-target interaction prediction , 2022, Bioinform..
[16] Bo Jin,et al. DeepMGT-DTI: Transformer network incorporating multilayer graph information for Drug-Target interaction prediction , 2022, Comput. Biol. Medicine.
[17] Mansoor Zolghadri Jahromi,et al. Drug-target continuous binding affinity prediction using multiple sources of information , 2021, Expert Syst. Appl..
[18] Xing Chen,et al. Predicting potential small molecule-miRNA associations based on bounded nuclear norm regularization , 2021, Briefings Bioinform..
[19] M. Zolghadri Jahromi,et al. Binding affinity prediction for binary drug–target interactions using semi-supervised transfer learning , 2021, Journal of Computer-Aided Molecular Design.
[20] Zhijian Xu,et al. MultiDTI: drug-target interaction prediction based on multi-modal representation learning to bridge the gap between new chemical entities and known heterogeneous network , 2021, Bioinform..
[21] I. Sohn,et al. Prediction of drug–target binding affinity using similarity-based convolutional neural network , 2021, Scientific Reports.
[22] Jimeng Sun,et al. DeepPurpose: a deep learning library for drug–target interaction prediction , 2020, Bioinform..
[23] Parvin Razzaghi,et al. DeepCDA: deep cross-domain compound-protein affinity prediction through LSTM and convolutional neural networks , 2020, Bioinform..
[24] Ce Liu,et al. Supervised Contrastive Learning , 2020, NeurIPS.
[25] Geoffrey E. Hinton,et al. A Simple Framework for Contrastive Learning of Visual Representations , 2020, ICML.
[26] Kayvan Najarian,et al. Machine learning approaches and databases for prediction of drug–target interaction: a survey paper , 2020, Briefings Bioinform..
[27] Angshul Majumdar,et al. Drug-target interaction prediction using Multi Graph Regularized Nuclear Norm Minimization , 2020, PloS one.
[28] Xiaoli Li,et al. Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey , 2019, Briefings Bioinform..
[29] Xing Chen,et al. MicroRNA-small molecule association identification: from experimental results to computational models , 2018, Briefings Bioinform..
[30] Jie Li,et al. Review of Drug Repositioning Approaches and Resources , 2018, International journal of biological sciences.
[31] Di Wu,et al. DeepAffinity: Interpretable Deep Learning of Compound-Protein Affinity through Unified Recurrent and Convolutional Neural Networks , 2018, bioRxiv.
[32] Tao Jiang,et al. NeoDTI: Neural integration of neighbor information from a heterogeneous network for discovering new drug-target interactions , 2018, bioRxiv.
[33] Arzucan Özgür,et al. DeepDTA: deep drug–target binding affinity prediction , 2018, Bioinform..
[34] Artem Cherkasov,et al. SimBoost: a read-across approach for predicting drug–target binding affinities using gradient boosting machines , 2017, Journal of Cheminformatics.
[35] Jian Peng,et al. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information , 2017, Nature Communications.
[36] S. Niu,et al. Deep-Learning-Based Drug-Target Interaction Prediction. , 2017, Journal of proteome research.
[37] Kihyuk Sohn,et al. Improved Deep Metric Learning with Multi-class N-pair Loss Objective , 2016, NIPS.
[38] Yongdong Zhang,et al. Drug-target interaction prediction: databases, web servers and computational models , 2016, Briefings Bioinform..
[39] P. Garg,et al. An improved approach for predicting drug-target interaction: proteochemometrics to molecular docking. , 2016, Molecular bioSystems.
[40] James Philbin,et al. FaceNet: A unified embedding for face recognition and clustering , 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[41] Xiang Zhang,et al. Drug repositioning by integrating target information through a heterogeneous network model , 2014, Bioinform..
[42] T. Aittokallio,et al. Toward more realistic drug–target interaction predictions , 2014, Briefings Bioinform..
[43] Tao Xu,et al. Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis , 2014, J. Chem. Inf. Model..
[44] Thomas C. Wiegers,et al. The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..
[45] Mindy I. Davis,et al. Comprehensive analysis of kinase inhibitor selectivity , 2011, Nature Biotechnology.
[46] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[47] P. Bork,et al. A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.
[48] K. S. Deshpande,et al. Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..
[49] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[50] Yann LeCun,et al. Dimensionality Reduction by Learning an Invariant Mapping , 2006, 2006 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (CVPR'06).
[51] Kilian Q. Weinberger,et al. Distance Metric Learning for Large Margin Nearest Neighbor Classification , 2005, NIPS.
[52] OUP accepted manuscript , 2022, Bioinformatics.
[53] Thin Nguyen1,et al. GraphDTA: Predicting drug–target binding affinity with graph neural networks , 2022 .